Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1001/archpedi.154.10.979 http://scihub22266oqcxt.onion/10.1001/archpedi.154.10.979 11030848!ä!11030848 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arch+Pediatr+Adolesc+Med 2000 ; 154 (10): 979-83 Nephropedia Template TP {{tp|p=11030848|t=2000. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma |pdf=|usr=}}{{11030848}} gab.com Text Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma JO: Arch Pediatr Adolesc Med http://www.kidney.de/pget.php?&tw=1&pmid=11030848 #FOAvip OBJECTIVE: To evaluate the efficacy of a 40-mg/kg dose of intravenous magnesium sulfate for moderate to severe asthma exacerbations in pediatric patients. STUDY DESIGN: Double-blind placebo-controlled trial. SETTING: Two urban tertiary care pediatric emergency departments. SUBJECTS: Thirty patients, aged 6 to 17.9 years, being treated for an acute asthma exacerbation. INTERVENTION: Eligible patients received either a magnesium sulfate infusion of 40 mg/kg or saline solution. RESULTS: At 20 minutes, the time at which the infusion was completed, the magnesium group had a significantly greater percentage of absolute improvement from baseline in each of the following: predicted peak expiratory flow rate (8.6% vs 0.3%, P<. 001), forced expiratory volume in 1 second (7.0% vs 0.2%,P<.001), and forced vital capacity (7.3% vs -0.7%, P<.001). The improvement was greater at 110 minutes: peak expiratory flow rate (25.8% vs 1.9%, P<.001), forced expiratory volume in 1 second (24.1% vs 2.3%; P<. 001), and forced vital capacity (27.3% vs 2.6%, P<.001). Patients who received intravenous magnesium were more likely to be discharged to their homes than those who received the placebo (8/16 vs 0/14; P=. 002). CONCLUSION: Children treated with 40 mg/kg of intravenous magnesium sulfate for moderate to severe asthma showed remarkable improvement in short-term pulmonary function. Twit Text FOAVip Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma ????Arch Pediatr Adolesc Med http://www.kidney.de/pget.php?&tw=1&pmid=11030848 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=11030848 #FOAvip English Wikipedia <ref>{{Cite pmid|11030848}}</ref> Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma #MMPMID11030848 Ciarallo L; Brousseau D; Reinert S Arch Pediatr Adolesc Med 2000[Oct]; 154 (10): 979-83 PMID11030848show ga OBJECTIVE: To evaluate the efficacy of a 40-mg/kg dose of intravenous magnesium sulfate for moderate to severe asthma exacerbations in pediatric patients. STUDY DESIGN: Double-blind placebo-controlled trial. SETTING: Two urban tertiary care pediatric emergency departments. SUBJECTS: Thirty patients, aged 6 to 17.9 years, being treated for an acute asthma exacerbation. INTERVENTION: Eligible patients received either a magnesium sulfate infusion of 40 mg/kg or saline solution. RESULTS: At 20 minutes, the time at which the infusion was completed, the magnesium group had a significantly greater percentage of absolute improvement from baseline in each of the following: predicted peak expiratory flow rate (8.6% vs 0.3%, P<. 001), forced expiratory volume in 1 second (7.0% vs 0.2%,P<.001), and forced vital capacity (7.3% vs -0.7%, P<.001). The improvement was greater at 110 minutes: peak expiratory flow rate (25.8% vs 1.9%, P<.001), forced expiratory volume in 1 second (24.1% vs 2.3%; P<. 001), and forced vital capacity (27.3% vs 2.6%, P<.001). Patients who received intravenous magnesium were more likely to be discharged to their homes than those who received the placebo (8/16 vs 0/14; P=. 002). CONCLUSION: Children treated with 40 mg/kg of intravenous magnesium sulfate for moderate to severe asthma showed remarkable improvement in short-term pulmonary function. |*Severity of Illness Index[MESH] |Adolescent[MESH] |Asthma/classification/diagnosis/*drug therapy/physiopathology[MESH] |Calcium Channel Blockers/*administration & dosage/pharmacology[MESH] |Child[MESH] |Double-Blind Method[MESH] |Emergency Treatment/*methods[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Forced Expiratory Volume/drug effects[MESH] |Humans[MESH] |Infusions, Intravenous[MESH] |Magnesium Sulfate/*administration & dosage/pharmacology[MESH] |Male[MESH] |Peak Expiratory Flow Rate/drug effects[MESH] |Time Factors[MESH]Higher-dose intravenous magnesium therapy for children with moderate t(epmc).pdf DeepDyve Pubget Overpricing